ÂÜÀòÂÒÂ×

Tina Abild Olesen has extensive experience in the pharmaceutical industry, currently serving as Senior Vice President of the Diabetes franchise and Global Commercial Strategy at Novo Nordisk since February 2009. Olesen has held various senior leadership roles, including General Manager & Corporate Vice President and Marketing Director for Diabetes & Obesity. Additionally, Olesen is a Board Member at Embla Medical and serves as Vice Chairman of the Board at the World Diabetes Foundation. Prior experience includes a Business Unit Director role at GSK and various positions in Corporate Affairs, Marketing, and Sales. Olesen's academic credentials include an M. Sc. in Economics & Business Administration from Copenhagen Business School, as well as studies at INSEAD, Harvard University, Henley Business School, and Nottingham Trent University.